---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-24-000144"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T14:22:00.002079+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CONMED Q4 sales $327M (+30.4% YoY); adjusted EPS $1.06 (+152%); guides FY24 rev $1.34-1.365B

## Summary
- Q4 sales $327.0M, +30.4% YoY (31.5% constant currency); domestic +33.3%, intl +26.5% as reported.
- Q4 GAAP diluted EPS $1.05; adjusted diluted EPS $1.06, up 152.4% vs Q4 2022.
- FY2023 sales $1,244.7M (+19.1%); GAAP EPS $2.04 vs loss of $2.68; adjusted EPS $3.45 (+30.2%).
- FY2024 revenue guidance $1.340B-$1.365B (8-10% growth); adjusted EPS guidance $4.30-$4.40 (25-28% growth).
- Record revenue achieved in both Q4 and full year; balanced growth across General Surgery and Orthopedics.

## SEC filing metadata
- accession: 0001174947-24-000144
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/0001174947-24-000144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/form8k-31428_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-24-000144
- JSON: https://secwatch.observer/filing/0001174947-24-000144.json
- Plain text: https://secwatch.observer/filing/0001174947-24-000144.txt

## Key facts
- Earnings Releases
  CONMED Corp reported financial results for the fourth quarter and full-year ended December 31, 2023.
  - Period: the fourth quarter and full-year ended December 31, 2023
  - Result: reported results
  source text: On January 31, 2024, CONMED Corporation issued a press release announcing financial results for the fourth quarter ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/0001174947-24-000144-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.